New promising molecular targets in head and neck squamous cell carcinoma

Julie E Bauman1, Loren S Michel, Christine H Chung

  • 1Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.

Current Opinion in Oncology
|February 14, 2012
PubMed
Abstract

Insights

This review explores novel therapeutic targets for head and neck squamous cell carcinoma (HNSCC). Advances in understanding HNSCC biology offer new possibilities for improved patient outcomes.

Area of Science:

  • Oncology
  • Translational Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) has a suboptimal 5-year survival rate (40-50%) despite multimodality treatments.
  • Current therapies for HNSCC are associated with significant toxicities.
  • Risk factors include tobacco, alcohol, and increasingly, human papillomavirus (HPV).

Purpose of the Study:

  • To review promising therapeutic targets for HNSCC.
  • To highlight recent advances in understanding HNSCC biology and their clinical implications.

Main Methods:

  • Review of recent scientific literature on HNSCC.
  • Analysis of data from whole exome sequencing.
  • Evaluation of insights into DNA damage repair and tumor hypoxia.

Main Results:

  • Human papillomavirus (HPV) is identified as a key therapeutic target in HNSCC.
  • Whole exome sequencing reveals new insights into HNSCC genetic landscape.
  • Understanding of DNA damage repair and tumor hypoxia opens new therapeutic avenues.

Conclusions:

  • HNSCC is a complex and heterogeneous disease.
  • Effective treatment requires translating basic science discoveries into clinical practice.
  • Development of novel therapeutics and predictive biomarkers is crucial for advancing HNSCC care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...